These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4049417)

  • 1. Structural requirements for cytoprotective agents in galactosamine-induced hepatic necrosis.
    MacDonald JR; Gandolfi AJ; Sipes IG
    Toxicol Appl Pharmacol; 1985 Oct; 81(1):17-24. PubMed ID: 4049417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystamine modulation of galactosamine-induced hepatotoxicity.
    MacDonald JR; Gandolfi AJ; Sipes IG
    Toxicol Appl Pharmacol; 1984 May; 73(3):551-8. PubMed ID: 6719469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of galactosamine cytotoxicity in an in vivo/in vitro hepatocellular toxicity model.
    MacDonald JR; Thayer KJ; White C
    Toxicol Appl Pharmacol; 1987 Jun; 89(2):269-77. PubMed ID: 3603561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinecrotic effect of 3-palmitoyl-(+)-catechin against liver damage induced by galactosamine or ethanol in the rat.
    Perrissoud D; Maignan MF; Dumont JM
    Liver; 1985 Apr; 5(2):55-63. PubMed ID: 3999934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic cysteamine and non-protein sulfhydryl levels following cystamine or cysteamine treatment of galactosamine-poisoned rats.
    MacDonald JR; Gandolfi AJ; Sipes IG
    Drug Chem Toxicol; 1985; 8(6):483-94. PubMed ID: 4092620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the hepatotoxicity of D-galactosamine in the rat by cycloheximide.
    Koff RS; Connelly LJ
    Proc Soc Exp Biol Med; 1976 Mar; 151(3):519-22. PubMed ID: 1257252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of galactosamine-induced liver injury by some amino acids or Triton WR1339.
    de Ferreyra EC; de Fenos OM; Castro JA
    Toxicol Lett; 1983 Apr; 16(1-2):63-7. PubMed ID: 6836615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological studies on schizandra fruits. III. Effects of wuweizisu C, a lignan component of schizandra fruits, on experimental liver injuries in rats].
    Takeda S; Funo S; Iizuka A; Kase Y; Arai I; Ohkura Y; Sudo K; Kiuchi N; Yoshida C; Maeda S
    Nihon Yakurigaku Zasshi; 1985 Mar; 85(3):193-208. PubMed ID: 2989131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of protective effect of D-003, a mixture of high-molecular-weight primary acids from sugar cane wax, on liver damage induced by galactosamine in rats.
    Noa M; Mendoza S; Mas R; Mendoza N
    J Med Food; 2005; 8(3):343-7. PubMed ID: 16176145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cysteamine, cystamine, and the structurally related compounds taurine, N-acetyl-cysteine, and D-penicillamine on plasma prolactin levels in normal and estrogen-primed hyperprolactinemic rats.
    Scott JS; Lakin CA; Oliver JR
    Endocrinology; 1987 Aug; 121(2):812-8. PubMed ID: 3109888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epoxysuccinic acid derivative(loxistatin)-induced hepatic injury in rats and hamsters.
    Fukushima K; Arai M; Kohno Y; Suwa T; Satoh T
    Toxicol Appl Pharmacol; 1990 Aug; 105(1):1-12. PubMed ID: 2392799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of hepatoprotection by epsilon aminocaproic acid and putrescine.
    Putnam CW; Buckley AR; Warneke JA; Karrer FM; Rhenman B; Steinbronn K
    Surgery; 1984 Aug; 96(2):214-22. PubMed ID: 6431622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in endogenous prostaglandin levels during D-galactosamine-induced liver injury.
    Koyama Y; Imoto M; Tanaka M; Fukuda Y; Satake T; Ozawa T
    Biochem Int; 1989 Aug; 19(2):421-8. PubMed ID: 2818605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pretreatment of rats with uracil on liver injuries induced by D-galactosamine and allyl alcohol.
    Kitajima S; Ogawa N; Ariyoshi T
    Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):14-20. PubMed ID: 7953190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted protection of hepatocytes from galactosamine toxicity in vivo.
    Keegan-Rogers V; Wu GY
    Cancer Chemother Pharmacol; 1990; 26(2):93-6. PubMed ID: 1693313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of malotilate against galactosamine intoxication in the rat.
    Dumont JM; Maignan MF; Perrissoud D
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):296-310. PubMed ID: 3426350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of propolis extract on D-galactosamine-induced hepatic injury in rats.
    Sugimoto Y; Tarumi T; Kaneko Y; Isayama S; Kawai N; Sugimoto H; Yamada H; Kamei C
    Biol Pharm Bull; 1999 Nov; 22(11):1237-9. PubMed ID: 10598035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in taurine as an indicator of hepatic dysfunction and biochemical perturbations. Studies in vivo and in vitro.
    Timbrell JA; Waterfield CJ
    Adv Exp Med Biol; 1996; 403():125-34. PubMed ID: 8915350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of zinc on liver injury induced by D-galactosamine in rats.
    Hu HL; Chen RD; Ma LH
    Biol Trace Elem Res; 1992 Jul; 34(1):27-33. PubMed ID: 1382519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystamine treatment of chemically induced liver injury.
    MacDonald JR; Gandolfi AJ; Sipes IG
    Dev Toxicol Environ Sci; 1983; 11():463-6. PubMed ID: 6677487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.